Free Trial

Sernova (SVA) Competitors

Sernova logo
C$0.20 -0.01 (-4.76%)
As of 01/20/2025 03:35 PM Eastern

SVA vs. ABCN, EMC, FRX, BCT, IPA, TH, SCYB, COM, MDNA, and NVH

Should you be buying Sernova stock or one of its competitors? The main competitors of Sernova include VIVO Cannabis (ABCN), Emblem (EMC), Fennec Pharmaceuticals (FRX), BriaCell Therapeutics (BCT), ImmunoPrecise Antibodies (IPA), Theratechnologies (TH), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Medicenna Therapeutics (MDNA), and Novoheart (NVH). These companies are all part of the "biotechnology" industry.

Sernova vs.

Sernova (TSE:SVA) and VIVO Cannabis (CVE:ABCN) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability, risk and media sentiment.

Sernova currently has a consensus price target of C$1.83, suggesting a potential upside of 816.67%. Given Sernova's stronger consensus rating and higher probable upside, analysts clearly believe Sernova is more favorable than VIVO Cannabis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sernova
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.00
VIVO Cannabis
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SernovaN/AN/A-C$38.93M-C$0.13-1.54
VIVO CannabisN/AN/AN/AN/AN/A

In the previous week, Sernova had 3 more articles in the media than VIVO Cannabis. MarketBeat recorded 3 mentions for Sernova and 0 mentions for VIVO Cannabis. VIVO Cannabis' average media sentiment score of 0.00 beat Sernova's score of -0.08 indicating that VIVO Cannabis is being referred to more favorably in the news media.

Company Overall Sentiment
Sernova Neutral
VIVO Cannabis Neutral

0.1% of Sernova shares are owned by institutional investors. 12.1% of Sernova shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

VIVO Cannabis received 117 more outperform votes than Sernova when rated by MarketBeat users. However, 91.67% of users gave Sernova an outperform vote while only 71.91% of users gave VIVO Cannabis an outperform vote.

CompanyUnderperformOutperform
SernovaOutperform Votes
11
91.67%
Underperform Votes
1
8.33%
VIVO CannabisOutperform Votes
128
71.91%
Underperform Votes
50
28.09%

VIVO Cannabis' return on equity of 0.00% beat Sernova's return on equity.

Company Net Margins Return on Equity Return on Assets
SernovaN/A -726.29% -119.26%
VIVO Cannabis N/A N/A N/A

Summary

Sernova beats VIVO Cannabis on 8 of the 12 factors compared between the two stocks.

Get Sernova News Delivered to You Automatically

Sign up to receive the latest news and ratings for SVA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SVA vs. The Competition

MetricSernovaBiotechnology IndustryMedical SectorTSE Exchange
Market CapC$65.06MC$173.63MC$5.21BC$6.17B
Dividend Yield7.86%3.64%5.13%5.77%
P/E Ratio-1.54132.3589.5626.04
Price / SalesN/A20,520.221,332.951,270.19
Price / Cash6.1513.0143.7582.58
Price / Book-5.009.345.313.20
Net Income-C$38.93M-C$20.89MC$122.54MC$295.15M
7 Day Performance-6.98%0.26%1.46%2.20%
1 Month Performance-13.04%1.92%2.53%3.37%
1 Year Performance-67.21%126.00%25.34%39.56%

Sernova Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SVA
Sernova
2.3374 of 5 stars
C$0.20
-4.8%
C$1.83
+816.7%
-67.2%C$65.06MN/A-1.541,959News Coverage
ABCN
VIVO Cannabis
N/AC$1.32
+5.6%
N/A+0.0%C$256.62MN/A0.00N/AGap Up
EMC
Emblem
N/A$1.88
+1.6%
N/A+0.0%$245.45M$5.71M-9.89N/A
FRX
Fennec Pharmaceuticals
N/AC$8.40
-2.2%
N/AN/AC$229.82MC$48.89M84.0010Gap Down
BCT
BriaCell Therapeutics
N/AC$10.60
-3.8%
C$15.00
+41.5%
+0.0%C$168.68MN/A-28.195
IPA
ImmunoPrecise Antibodies
N/AC$6.50
+0.8%
N/A+0.0%C$162.08MC$19.47M-7.3080Gap Down
TH
Theratechnologies
N/AC$2.40
-10.8%
N/A-3.8%C$110.35MC$82.57M-13.33103Gap Down
SCYB
Scythian Biosciences
N/AC$3.49
-5.9%
N/A+0.0%C$102.38MN/A0.00N/AHigh Trading Volume
COM
138267 (COM.TO)
N/AN/AN/AN/AC$102.19MN/A0.00N/A
MDNA
Medicenna Therapeutics
N/AC$1.32
-3.6%
N/A+213.3%C$100.89MN/A-3.4720Positive News
NVH
Novoheart
N/AC$0.53
+1.9%
N/A+0.0%C$99.98MC$423,500.00-13.95N/A

Related Companies and Tools


This page (TSE:SVA) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners